APO Research
Talk to an analyst

APO RESEARCH · REPORT

CGRP Targeting Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global CGRP Targeting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025186 pages

Choose your research edition.

Industry ResearchCGRP Targeting Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal CGRP Targeting Drugs Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal CGRP Targeting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CGRP Targeting Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal CGRP Targeting Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global CGRP Targeting Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for CGRP Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for CGRP Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for CGRP Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for CGRP Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of CGRP Targeting Drugs include Alder Therapeutics, AbbVie Inc., Amgen Inc., Daiichi Sankyo Co., Ltd., Pfizer Inc., Lilly Inc., Lundbeck, Novartis International AG and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global CGRP Targeting Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of CGRP Targeting Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents CGRP Targeting Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the CGRP Targeting Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

CGRP Targeting Drugs Segment by Company

Alder Therapeutics

AbbVie Inc.

Amgen Inc.

Daiichi Sankyo Co., Ltd.

Pfizer Inc.

Lilly Inc.

Lundbeck

Novartis International AG

Teva

CGRP Targeting Drugs Segment by Type

CGRP Receptor Antagonists

CGRP Monoclonal Antibodies

CGRP Targeting Drugs Segment by Application

Specialty Clinic

Hospital

Others

CGRP Targeting Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CGRP Targeting Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CGRP Targeting Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CGRP Targeting Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of CGRP Targeting Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CGRP Targeting Drugs industry.

Chapter 3: Detailed analysis of CGRP Targeting Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CGRP Targeting Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global CGRP Targeting Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of CGRP Receptor Antagonists Table 3. Key Players of CGRP Monoclonal Antibodies Table 4. Global CGRP Targeting Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Specialty Clinic Table 6. Key Players of Hospital Table 7. Key Players of Others Table 8. Global CGRP Targeting Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global CGRP Targeting Drugs Market Size by Region (2021-2026) & (US$ Million) Table 10. Global CGRP Targeting Drugs Market Share by Region (2021-2026) Table 11. Global CGRP Targeting Drugs Market Size by Region (2027-2032) & (US$ Million) Table 12. Global CGRP Targeting Drugs Market Share by Region (2027-2032) Table 13. CGRP Targeting Drugs Industry Trends Table 14. CGRP Targeting Drugs Industry Drivers Table 15. CGRP Targeting Drugs Industry Opportunities and Challenges Table 16. CGRP Targeting Drugs Industry Restraints Table 17. Global CGRP Targeting Drugs Revenue by Company (US$ Million) & (2021-2026) Table 18. Global CGRP Targeting Drugs Revenue Market Share by Company (2021-2026) Table 19. Global CGRP Targeting Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global CGRP Targeting Drugs Key Company Head Office and Area Served Table 21. Global CGRP Targeting Drugs Company, Product Type & Application Table 22. Global CGRP Targeting Drugs Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global CGRP Targeting Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global CGRP Targeting Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global CGRP Targeting Drugs Market Size by Type (2021-2026) & (US$ Million) Table 27. Global CGRP Targeting Drugs Market Size by Type (2027-2032) & (US$ Million) Table 28. Global CGRP Targeting Drugs Revenue Market Share by Type (2021-2026) Table 29. Global CGRP Targeting Drugs Revenue Market Share by Type (2027-2032) Table 30. Global CGRP Targeting Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global CGRP Targeting Drugs Market Size by Application (2021-2026) & (US$ Million) Table 32. Global CGRP Targeting Drugs Market Size by Application (2027-2032) & (US$ Million) Table 33. Global CGRP Targeting Drugs Revenue Market Share by Application (2021-2026) Table 34. Global CGRP Targeting Drugs Revenue Market Share by Application (2027-2032) Table 35. Alder Therapeutics Company Information Table 36. Alder Therapeutics Business Overview Table 37. Alder Therapeutics CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Alder Therapeutics CGRP Targeting Drugs Product Portfolio Table 39. Alder Therapeutics Recent Development Table 40. AbbVie Inc. Company Information Table 41. AbbVie Inc. Business Overview Table 42. AbbVie Inc. CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. AbbVie Inc. CGRP Targeting Drugs Product Portfolio Table 44. AbbVie Inc. Recent Development Table 45. Amgen Inc. Company Information Table 46. Amgen Inc. Business Overview Table 47. Amgen Inc. CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Amgen Inc. CGRP Targeting Drugs Product Portfolio Table 49. Amgen Inc. Recent Development Table 50. Daiichi Sankyo Co., Ltd. Company Information Table 51. Daiichi Sankyo Co., Ltd. Business Overview Table 52. Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs Product Portfolio Table 54. Daiichi Sankyo Co., Ltd. Recent Development Table 55. Pfizer Inc. Company Information Table 56. Pfizer Inc. Business Overview Table 57. Pfizer Inc. CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Pfizer Inc. CGRP Targeting Drugs Product Portfolio Table 59. Pfizer Inc. Recent Development Table 60. Lilly Inc. Company Information Table 61. Lilly Inc. Business Overview Table 62. Lilly Inc. CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Lilly Inc. CGRP Targeting Drugs Product Portfolio Table 64. Lilly Inc. Recent Development Table 65. Lundbeck Company Information Table 66. Lundbeck Business Overview Table 67. Lundbeck CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Lundbeck CGRP Targeting Drugs Product Portfolio Table 69. Lundbeck Recent Development Table 70. Novartis International AG Company Information Table 71. Novartis International AG Business Overview Table 72. Novartis International AG CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Novartis International AG CGRP Targeting Drugs Product Portfolio Table 74. Novartis International AG Recent Development Table 75. Teva Company Information Table 76. Teva Business Overview Table 77. Teva CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Teva CGRP Targeting Drugs Product Portfolio Table 79. Teva Recent Development Table 80. North America CGRP Targeting Drugs Market Size by Type (2021-2026) & (US$ Million) Table 81. North America CGRP Targeting Drugs Market Size by Type (2027-2032) & (US$ Million) Table 82. North America CGRP Targeting Drugs Market Size by Application (2021-2026) & (US$ Million) Table 83. North America CGRP Targeting Drugs Market Size by Application (2027-2032) & (US$ Million) Table 84. North America CGRP Targeting Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America CGRP Targeting Drugs Market Size by Country (2021-2026) Table 86. North America CGRP Targeting Drugs Market Size by Country (2027-2032) Table 87. Europe CGRP Targeting Drugs Market Size by Type (2021-2026) & (US$ Million) Table 88. Europe CGRP Targeting Drugs Market Size by Type (2027-2032) & (US$ Million) Table 89. Europe CGRP Targeting Drugs Market Size by Application (2021-2026) & (US$ Million) Table 90. Europe CGRP Targeting Drugs Market Size by Application (2027-2032) & (US$ Million) Table 91. Europe CGRP Targeting Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe CGRP Targeting Drugs Market Size by Country (2021-2026) Table 93. Europe CGRP Targeting Drugs Market Size by Country (2027-2032) Table 94. China CGRP Targeting Drugs Market Size by Type (2021-2026) & (US$ Million) Table 95. China CGRP Targeting Drugs Market Size by Type (2027-2032) & (US$ Million) Table 96. China CGRP Targeting Drugs Market Size by Application (2021-2026) & (US$ Million) Table 97. China CGRP Targeting Drugs Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia CGRP Targeting Drugs Market Size by Type (2021-2026) & (US$ Million) Table 99. Asia CGRP Targeting Drugs Market Size by Type (2027-2032) & (US$ Million) Table 100. Asia CGRP Targeting Drugs Market Size by Application (2021-2026) & (US$ Million) Table 101. Asia CGRP Targeting Drugs Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia CGRP Targeting Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia CGRP Targeting Drugs Market Size by Country (2021-2026) Table 104. Asia CGRP Targeting Drugs Market Size by Country (2027-2032) Table 105. South America, Middle East & Africa CGRP Targeting Drugs Market Size by Type (2021-2026) & (US$ Million) Table 106. South America, Middle East & Africa CGRP Targeting Drugs Market Size by Type (2027-2032) & (US$ Million) Table 107. South America, Middle East & Africa CGRP Targeting Drugs Market Size by Application (2021-2026) & (US$ Million) Table 108. South America, Middle East & Africa CGRP Targeting Drugs Market Size by Application (2027-2032) & (US$ Million) Table 109. South America, Middle East & Africa CGRP Targeting Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. South America, Middle East & Africa CGRP Targeting Drugs Market Size by Country (2021-2026) Table 111. South America, Middle East & Africa CGRP Targeting Drugs Market Size by Country (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. CGRP Targeting Drugs Product Image Figure 2. Global CGRP Targeting Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global CGRP Targeting Drugs Market Share by Type: 2025 VS 2032 Figure 4. CGRP Receptor Antagonists Image Figure 5. CGRP Monoclonal Antibodies Image Figure 6. Global CGRP Targeting Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global CGRP Targeting Drugs Market Share by Application: 2025 VS 2032 Figure 8. Specialty Clinic Image Figure 9. Hospital Image Figure 10. Others Image Figure 11. Global CGRP Targeting Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 13. Global CGRP Targeting Drugs Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global CGRP Targeting Drugs Market Share by Players in 2025 Figure 16. Global Top 5 and 10 CGRP Targeting Drugs Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global CGRP Targeting Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global CGRP Targeting Drugs Revenue Market Share by Type (2021-2032) Figure 20. Global CGRP Targeting Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global CGRP Targeting Drugs Revenue Market Share by Application (2021-2032) Figure 22. North America CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 23. North America CGRP Targeting Drugs Market Share by Type (2021-2032) Figure 24. North America CGRP Targeting Drugs Market Share by Application (2021-2032) Figure 25. North America CGRP Targeting Drugs Market Share by Country (2021-2032) Figure 26. United States CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 27. Canada CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 28. Mexico CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Europe CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Europe CGRP Targeting Drugs Market Share by Type (2021-2032) Figure 31. Europe CGRP Targeting Drugs Market Share by Application (2021-2032) Figure 32. Europe CGRP Targeting Drugs Market Share by Country (2021-2032) Figure 33. Germany CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 34. France CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 35. U.K. CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 36. Italy CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 37. Russia CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 39. China CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 40. China CGRP Targeting Drugs Market Share by Type (2021-2032) Figure 41. China CGRP Targeting Drugs Market Share by Application (2021-2032) Figure 42. Asia CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 43. Asia CGRP Targeting Drugs Market Share by Type (2021-2032) Figure 44. Asia CGRP Targeting Drugs Market Share by Application (2021-2032) Figure 45. Asia CGRP Targeting Drugs Market Share by Country (2021-2032) Figure 46. Japan CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 47. South Korea CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 50. India CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Australia CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa CGRP Targeting Drugs Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa CGRP Targeting Drugs Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa CGRP Targeting Drugs Market Share by Country (2021-2032) Figure 56. Brazil CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 57. South Africa CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 59. Turkey CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Argentina CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 61. UAE CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Egypt CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 63. Chile CGRP Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • CGRP Receptor Antagonists
  • CGRP Monoclonal Antibodies
Applications
  • Specialty Clinic
  • Hospital
  • Others
Companies covered
  • Alder Therapeutics
  • AbbVie Inc.
  • Amgen Inc.
  • Daiichi Sankyo Co., Ltd.
  • Pfizer Inc.
  • Lilly Inc.
  • Lundbeck
  • Novartis International AG
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global CGRP Targeting Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 CGRP Receptor Antagonists
  5. 1.2.3 CGRP Monoclonal Antibodies
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global CGRP Targeting Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Specialty Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global CGRP Targeting Drugs Growth Trends by Region
  13. 1.5.1 Global CGRP Targeting Drugs Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 CGRP Targeting Drugs Market Size by Region (2021-2026)
  15. 1.5.3 CGRP Targeting Drugs Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global CGRP Targeting Drugs Market Dynamics
  1. 2.1 CGRP Targeting Drugs Industry Trends
  2. 2.2 CGRP Targeting Drugs Industry Drivers
  3. 2.3 CGRP Targeting Drugs Industry Opportunities and Challenges
  4. 2.4 CGRP Targeting Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global CGRP Targeting Drugs Revenue by Company (2021-2026)
  2. 3.2 Global CGRP Targeting Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global CGRP Targeting Drugs Key Company Head office and Area Served
  4. 3.4 Global CGRP Targeting Drugs Company, Product Type & Application
  5. 3.5 Global CGRP Targeting Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global CGRP Targeting Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 CGRP Targeting Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 CGRP Targeting Drugs Tier 1, Tier 2, and Tier 3
4 CGRP Targeting Drugs Market by Type
  1. 4.1 Global CGRP Targeting Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global CGRP Targeting Drugs Market Size by Type (2021-2032)
  3. 4.3 Global CGRP Targeting Drugs Market Size Share by Type (2021-2032)
5 CGRP Targeting Drugs Market by Application
  1. 5.1 Global CGRP Targeting Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global CGRP Targeting Drugs Market Size by Application (2021-2032)
  3. 5.3 Global CGRP Targeting Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Alder Therapeutics
  2. 6.1.1 Alder Therapeutics Company Information
  3. 6.1.2 Alder Therapeutics Business Overview
  4. 6.1.3 Alder Therapeutics CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Alder Therapeutics CGRP Targeting Drugs Product Portfolio
  6. 6.1.5 Alder Therapeutics Recent Developments
  7. 6.2 AbbVie Inc.
  8. 6.2.1 AbbVie Inc. Company Information
  9. 6.2.2 AbbVie Inc. Business Overview
  10. 6.2.3 AbbVie Inc. CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 AbbVie Inc. CGRP Targeting Drugs Product Portfolio
  12. 6.2.5 AbbVie Inc. Recent Developments
  13. 6.3 Amgen Inc.
  14. 6.3.1 Amgen Inc. Company Information
  15. 6.3.2 Amgen Inc. Business Overview
  16. 6.3.3 Amgen Inc. CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Amgen Inc. CGRP Targeting Drugs Product Portfolio
  18. 6.3.5 Amgen Inc. Recent Developments
  19. 6.4 Daiichi Sankyo Co., Ltd.
  20. 6.4.1 Daiichi Sankyo Co., Ltd. Company Information
  21. 6.4.2 Daiichi Sankyo Co., Ltd. Business Overview
  22. 6.4.3 Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs Product Portfolio
  24. 6.4.5 Daiichi Sankyo Co., Ltd. Recent Developments
  25. 6.5 Pfizer Inc.
  26. 6.5.1 Pfizer Inc. Company Information
  27. 6.5.2 Pfizer Inc. Business Overview
  28. 6.5.3 Pfizer Inc. CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pfizer Inc. CGRP Targeting Drugs Product Portfolio
  30. 6.5.5 Pfizer Inc. Recent Developments
  31. 6.6 Lilly Inc.
  32. 6.6.1 Lilly Inc. Company Information
  33. 6.6.2 Lilly Inc. Business Overview
  34. 6.6.3 Lilly Inc. CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Lilly Inc. CGRP Targeting Drugs Product Portfolio
  36. 6.6.5 Lilly Inc. Recent Developments
  37. 6.7 Lundbeck
  38. 6.7.1 Lundbeck Company Information
  39. 6.7.2 Lundbeck Business Overview
  40. 6.7.3 Lundbeck CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Lundbeck CGRP Targeting Drugs Product Portfolio
  42. 6.7.5 Lundbeck Recent Developments
  43. 6.8 Novartis International AG
  44. 6.8.1 Novartis International AG Company Information
  45. 6.8.2 Novartis International AG Business Overview
  46. 6.8.3 Novartis International AG CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Novartis International AG CGRP Targeting Drugs Product Portfolio
  48. 6.8.5 Novartis International AG Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva CGRP Targeting Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Teva CGRP Targeting Drugs Product Portfolio
  54. 6.9.5 Teva Recent Developments
7 North America
  1. 7.1 North America CGRP Targeting Drugs Market Size (2021-2032)
  2. 7.2 North America CGRP Targeting Drugs Market Size by Type
  3. 7.2.1 North America CGRP Targeting Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America CGRP Targeting Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America CGRP Targeting Drugs Market Share by Type (2021-2032)
  6. 7.3 North America CGRP Targeting Drugs Market Size by Application
  7. 7.3.1 North America CGRP Targeting Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America CGRP Targeting Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America CGRP Targeting Drugs Market Share by Application (2021-2032)
  10. 7.4 North America CGRP Targeting Drugs Market Size by Country
  11. 7.4.1 North America CGRP Targeting Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America CGRP Targeting Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America CGRP Targeting Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America CGRP Targeting Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe CGRP Targeting Drugs Market Size (2021-2032)
  2. 8.2 Europe CGRP Targeting Drugs Market Size by Type
  3. 8.2.1 Europe CGRP Targeting Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe CGRP Targeting Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe CGRP Targeting Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe CGRP Targeting Drugs Market Size by Application
  7. 8.3.1 Europe CGRP Targeting Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe CGRP Targeting Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe CGRP Targeting Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe CGRP Targeting Drugs Market Size by Country
  11. 8.4.1 Europe CGRP Targeting Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe CGRP Targeting Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe CGRP Targeting Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe CGRP Targeting Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China CGRP Targeting Drugs Market Size (2021-2032)
  2. 9.2 China CGRP Targeting Drugs Market Size by Type
  3. 9.2.1 China CGRP Targeting Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China CGRP Targeting Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China CGRP Targeting Drugs Market Share by Type (2021-2032)
  6. 9.3 China CGRP Targeting Drugs Market Size by Application
  7. 9.3.1 China CGRP Targeting Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China CGRP Targeting Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China CGRP Targeting Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia CGRP Targeting Drugs Market Size (2021-2032)
  2. 10.2 Asia CGRP Targeting Drugs Market Size by Type
  3. 10.2.1 Asia CGRP Targeting Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia CGRP Targeting Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia CGRP Targeting Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia CGRP Targeting Drugs Market Size by Application
  7. 10.3.1 Asia CGRP Targeting Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia CGRP Targeting Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia CGRP Targeting Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia CGRP Targeting Drugs Market Size by Country
  11. 10.4.1 Asia CGRP Targeting Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia CGRP Targeting Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia CGRP Targeting Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia CGRP Targeting Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa CGRP Targeting Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa CGRP Targeting Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa CGRP Targeting Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa CGRP Targeting Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa CGRP Targeting Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa CGRP Targeting Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa CGRP Targeting Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa CGRP Targeting Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa CGRP Targeting Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa CGRP Targeting Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa CGRP Targeting Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa CGRP Targeting Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa CGRP Targeting Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa CGRP Targeting Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst